Navigation Links
Jefferson urologist awarded Lifetime Achievement Award from Endourological Society
Date:10/27/2010

PHILADELPHIA Demetrius H. Bagley, M.D., the Nathan Lewis Hatfield Professor of Urology in the Department of Urology at Jefferson Medical College (JMC) of Thomas Jefferson University was recently honored as the 2010 recipient of the Karl Storz Lifetime Achievement Award in Endourology at the World Congress of Endourology. He is also a full Professor of Radiology.

"It is fitting that Dr. Bagley was chosen to receive the Karl Storz lifetime achievement award; having such a distinguished career in Endourology. He is an outstanding physician and a world-renowned researcher ," said Leonard Gomella, M.D., F.A.C.S., the Bernard W. Godwin, Jr. Professor of Prostate Cancer, and Chair of the Department of Urology at JMC. "The Department of Urology congratulates Dr. Bagley on this award and his numerous milestone accomplishments in the field of Endourology."

In announcing the award, the Executive Committee of the Endourological Society noted that Dr. Bagley was selected based on "his extensive work and pioneering advances in ureteroscopic management of upper tract pathology which have benefitted not only the Society but legions of endourologists throughout the world".

After receiving his undergraduate and medical degrees at Johns Hopkins University in Baltimore, Maryland, Dr. Bagley completed two years of General Surgery residency at Yale New Haven Hospital in New Haven, Connecticut, before completing a three-year fellowship in Oncology at the Surgery Branch of the National Cancer Institute in Bethesda, Maryland. Dr. Bagley completed his four-year urology residency at Yale New Haven Hospital. His first faculty appointment in urology was at the University of Chicago (1979�); he then joined Jefferson Medical College where he has been since.

Dr. Bagley is a member of the major urologic and endoscopic organizations and has been elected into the American Association ofGenitourinary Surgeons; and is the past president of the Philadelphia Urological Society. He is an associate member of Kimmel Cancer Center at Jefferson; and previously was Editor-in-Chief of Diagnostic and Therapeutic Endoscopy, an online journal. He is also an associate editor of the Journal of Endourology and a reviewer for the Journal of Urology, Urology and British Journal of Urology International. Dr. Bagley is the author, or co-author, of eight books on urologic endoscopy and has written over 300 original papers and chapters.

Dr. Bagley has been cited in Best Doctors in America and Philadelphia Magazine's ''Top Doctors'' for stone treatment and ureteroscopy. He is an internationally recognized expert in the field of endoscopy. His interests and expertise are in urologic endoscopy, laser therapy and the treatment of calculi and intrarenal neoplasms. He has been invited to speak nationally, as well as internationally in more than 30 different countries, on his experience in these fields.


'/>"/>

Contact: Ed Federico
ed.federico@jefferson.edu
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists
2. Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award
3. Jefferson physician named 2010 Emergency Department Director of the Year
4. Jefferson surgeon receives outstanding performance award from American College Of Surgeons
5. US neurologists agree on protocols for treatment of infantile spasms
6. Pediatric urologist performs innovative procedure for girls with rare vaginal defects
7. UAB Cancer Center, urologists affirm men should take lead in deciding prostate screening
8. Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis
9. University of Cincinnati neurotrauma team awarded $2.1M to test lab on a tube
10. National Medal of Science awarded to Stephen Benkovic of Penn State University
11. Additional $38M awarded to expand orthopedic trauma care research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... 2016 , ... According to an article published February 4th on ... portion of hernia repairs throughout the United States. Commenting on this article, Beverly Hills ... this trend has not only been expected, but it seems to be a natural ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills ... recruit top students from U.S. universities who will draw from Siemens’ deep ...
(Date:2/12/2016)... Church, VA (PRWEB) , ... February 12, 2016 ... ... Store?, Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... issue in the life cycle of pharmaceutical products, garnering increased attention from all ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... ... February 12, 2016 , ... Itopia, a ... the integration of Clarity Intelligence Platform (CIP) into Cielo®, a discovery, migration and ... intelligence (BI) to their small and medium business (SMB) clients. , ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... LONDON , Feb. 11, 2016 The ... current and future adoption patterns on the usage of ... include the following: - Timeframe of liquid ... types—CTCs, ctDNA, cfDNA and Evs—by organization type - Sample ... sample types: blood, saliva, stool, serum, and so on. ...
(Date:2/11/2016)... -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for ... Company also filed its Quarterly Report on Form 10-Q for ... and Exchange Commission today. --> ... --> --> Net sales for the three ... to $5.4 million from $2.8 million for the three months ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
Breaking Medicine Technology: